Introduction of pharmacogenetic screening to HIV clinical practice: Potential benefits and challenges

Mallal, S. and Phillips, E. (2007) Introduction of pharmacogenetic screening to HIV clinical practice: Potential benefits and challenges. European Infectious Diseases (2). pp. 13-18.

Abstract

It has long been recognised that individuals vary in their susceptibility to diseases and in their response to drugs, but it is only in the last 50 years that progress has been made in elucidating the genetic basis of this phenomenon. The term ‘pharmacogenetics’ was coined by Friedrich Vogel in 1959 to denote the effects of polymorphisms within a particular human gene on the disposition and action of drugs...

Item Type:	Journal Article
Murdoch Affiliation(s):	Centre for Clinical Immunology and Biomedical Statistics
Publisher:	Touch Briefings
Copyright:	2007 Touch Briefings
URI:	http://researchrepository.murdoch.edu.au/id/eprint/15079

Item Control Page

Downloads